The secret is for drug and insurance companies to think like Netflix.
are widely available, the minimum profitable price will be significantly less, since, ironically, the cost of the injector is a significant part of the cost of the product.Drug companies exist to make money, not help the maximum number of people possible. They’re not going to charge $40 for a drug when the market will bear 25 times that. But there’s actually a way that drug companies can give many, many more people access to a drug while also taking home a tidy profit.
I think we can all agree that there is not a snowball’s chance in heck that any insurance companies would be willing to pay $12,000 a year for a drug, except in the most extraordinary of circumstances. Yet Ozempic is covered for some of Kaiser’s members . But generally, it’s just not in Kaiser’s financial interests to greenlight a drug that a large portion of their members would qualify for, and for which the annual price of the drug is substantially more than the cost of an average plan.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New guidance suggests skipping Ozempic before surgeryDoctors are now cautioning people against taking Ozempic and other similar drugs before undergoing surgery or a procedure that requires them to be sedated.
Read more »
WeightWatchers members aren't happy with company's pivot to OzempicInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Read more »
What it's like to stay on Ozempic for years.NBCNews talked with with seven people who have been on Ozempic for between one and a half and two and a half years. All generally agreed that the medication was not a fast pass to good health.
Read more »
Does Anyone Else Find Hasbro's Groove 'N Grow Groot Incredibly Upsetting?Press a button and Groot 'til your branches fall off.
Read more »
UW study increases access to expensive Alzheimer’s treatmentMore people will have access to a new treatment for Alzheimer’s — thanks to a UW study
Read more »